BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32855391)

  • 1. RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction.
    Montalbano M; McAllen S; Puangmalai N; Sengupta U; Bhatt N; Johnson OD; Kharas MG; Kayed R
    Nat Commun; 2020 Aug; 11(1):4305. PubMed ID: 32855391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration.
    Montalbano M; McAllen S; Sengupta U; Puangmalai N; Bhatt N; Ellsworth A; Kayed R
    Aging Cell; 2019 Dec; 18(6):e13035. PubMed ID: 31532069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease.
    Sengupta U; Montalbano M; McAllen S; Minuesa G; Kharas M; Kayed R
    Acta Neuropathol Commun; 2018 Oct; 6(1):113. PubMed ID: 30367664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.
    Lester E; Ooi FK; Bakkar N; Ayers J; Woerman AL; Wheeler J; Bowser R; Carlson GA; Prusiner SB; Parker R
    Neuron; 2021 May; 109(10):1675-1691.e9. PubMed ID: 33848474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
    Collins M; Li Y; Bowser R
    Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
    Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
    PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.
    Eftekharzadeh B; Daigle JG; Kapinos LE; Coyne A; Schiantarelli J; Carlomagno Y; Cook C; Miller SJ; Dujardin S; Amaral AS; Grima JC; Bennett RE; Tepper K; DeTure M; Vanderburg CR; Corjuc BT; DeVos SL; Gonzalez JA; Chew J; Vidensky S; Gage FH; Mertens J; Troncoso J; Mandelkow E; Salvatella X; Lim RYH; Petrucelli L; Wegmann S; Rothstein JD; Hyman BT
    Neuron; 2018 Sep; 99(5):925-940.e7. PubMed ID: 30189209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
    Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
    J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.
    Rutherford NJ; Lewis J; Clippinger AK; Thomas MA; Adamson J; Cruz PE; Cannon A; Xu G; Golde TE; Shaw G; Borchelt DR; Giasson BI
    Brain Res; 2013 Aug; 1524():62-73. PubMed ID: 23774650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
    Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
    Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological tau drives ectopic nuclear speckle scaffold protein SRRM2 accumulation in neuron cytoplasm in Alzheimer's disease.
    McMillan PJ; Strovas TJ; Baum M; Mitchell BK; Eck RJ; Hendricks N; Wheeler JM; Latimer CS; Keene CD; Kraemer BC
    Acta Neuropathol Commun; 2021 Jun; 9(1):117. PubMed ID: 34187600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tau RNA maturation by thyroid hormone is mediated by the neural RNA-binding protein musashi-1.
    Cuadrado A; García-Fernández LF; Imai T; Okano H; Muñoz A
    Mol Cell Neurosci; 2002 Jun; 20(2):198-210. PubMed ID: 12093154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-Tau Impairs Nuclear-Cytoplasmic Transport.
    Tripathi T; Prakash J; Shav-Tal Y
    ACS Chem Neurosci; 2019 Jan; 10(1):36-38. PubMed ID: 30480430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
    Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
    Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
    Goedert M
    Curr Opin Genet Dev; 2001 Jun; 11(3):343-51. PubMed ID: 11377973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
    Younas N; Zafar S; Shafiq M; Noor A; Siegert A; Arora AS; Galkin A; Zafar A; Schmitz M; Stadelmann C; Andreoletti O; Ferrer I; Zerr I
    Acta Neuropathol; 2020 Sep; 140(3):317-339. PubMed ID: 32577828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
    Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
    J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.